Coave Therapeutics: redecorating viral vectors for improved gene therapies Coave Therapeutics is a French biotech developing gene therapies for neurodegenerative and ocular diseases. The company has developed a technology […] January 25, 2023 · V-Bio Ventures
Brewing up a new business: AB InBev surprises with ambitions for animal-free proteins Belgian-American AB InBev, the world’s largest brewer, has set up a separate R&D division called BioBrew to develop animal-free proteins […] January 25, 2023 · BioVox
Energizing the transition: ACROBAT consortium devises smart and sustainable ways to recycle LFP batteries Batteries are a crucial component of the energy transition away from fossil fuels, but the technology currently faces issues with […] January 25, 2023 · BioVox
The chaos of choice: how do people pick their food products? Every family needs groceries, and most people regularly venture to the supermarket to gather supplies. If researchers can help shoppers […] January 25, 2023 · SciMingo
Great at small things: BCCM stores microorganisms, plasmids, hybridomas, and more! BCCM is a Belgian non-profit consortium of seven biological resource centers preserving and distributing microbial and genetic resources, offering storage […] December 14, 2022 · Turnstone Communications
Why diversity matters in management teams, and how to achieve it The biotech industry is suffering from a serious talent shortage, with start-ups in particular having an increasingly hard time filling […] December 14, 2022 · V-Bio Ventures
Stew before you chew – why the way you cook pulses makes a difference to your nutrition Do you look at the composition or caloric content of foods to make healthy choices? In healthy foods, not only […] December 14, 2022 · SciMingo
MedTech Flanders becomes part of MEDVIA, Flanders’ healthtech spearhead cluster Ghent, Belgium, 13 December 2022 – MEDVIA was founded in 2021 as Flanders’ spearhead cluster focused on health technologies. It is […] December 13, 2022 · Turnstone Communications
From multiple pills per day to one treatment per month: progress in HIV medication made possible by pharma collaborations Unprecedented collaborations between different pharmaceutical companies have resulted in extraordinary progress for HIV patients over the past four decades. From […] December 5, 2022 · Janssen Pharmaceutica
Data science in early drug discovery – getting it right from the start The application of data science in the early stages of drug development is not new – progress in algorithms and […] November 24, 2022 · Janssen Pharmaceutica
Cancer vaccines: not only treating tumors, but preventing them too The COVID-19 pandemic has brought vaccines back into the drug development spotlight, and mRNA vaccines are stealing the show with […] November 23, 2022 · V-Bio Ventures
New personalized cancer vaccine in the making thanks to unique Belgian collaboration The young Belgian start-up Persomed is unique – it was founded in 2020 by four partners each with relevant expertise […] November 23, 2022 · BioVox
Marfan patients team up with researchers to catch their silent killer The world’s undiagnosed Marfan patients often go through life unaware of the hidden killer lurking in their DNA – a […] November 23, 2022 · SciMingo
Rejuvenate Biomed’s newly appointed Clinical Advisory Board endorses Clinical Phase 2b strategy in sarcopenia Diepenbeek, Belgium, 15 November 2022 – Rejuvenate Biomed NV (“Rejuvenate”), a biomedical company developing novel combination drugs for age-related diseases, […] November 15, 2022 · Turnstone Communications
Is Belgium becoming a hub for gene therapy? Ghent, Belgium, 10 November 2022 – Gene therapy provides solutions to deadly diseases. Is the technology ready for a big […] November 10, 2022 · Turnstone Communications